Role of the PD-1 and PD-L1 axis in COVID-19

Severe COVID-19 patients display dysregulated expression of checkpoint molecules PD-1 and its ligand PD-L1, suggesting that these checkpoint molecules could be considered as prognostic markers and therapeutic targets in severe cases of COVID-19.

Detalles Bibliográficos
Autores principales: R Bonam, Srinivasa, Hu, Haitao, Bayry, Jagadeesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332906/
https://www.ncbi.nlm.nih.gov/pubmed/35899493
http://dx.doi.org/10.2217/fmb-2022-0103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332906/
https://www.ncbi.nlm.nih.gov/pubmed/35899493
http://dx.doi.org/10.2217/fmb-2022-0103

Ejemplares similares